返回 Agenda
Session Chair(s)
Yasuhiro Fujiwara, MD, PHD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Concept and Implementation of Adaptive Licensing in EU (Remote presentation via internet)
Tomas Salmonson, DrMed, PHD
Critical Path Institute, Netherlands
Academic Expectation on the Future Drug Approval System
Yasuhiro Fujiwara, MD, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Industry Perspective on the System of Future Drug Approval
Satoshi Kawaoto
Novartis Pharma K.K., Japan
Corporate Officer, Head of Drug Regulatory Affairs Dept.
Regulatory Perspective on Future Direction of Drug Approval System in Japan
Daisaku Sato, PHD, MPHARM, RPH
Ministry of Health, Labour and Welfare, Japan
Councilor for Pharmaceutical Affairs